<DOC>
	<DOCNO>NCT01945307</DOCNO>
	<brief_summary>We need human blood understand immune response infection test promise new vaccine infectious disease laboratory . One test call Serum Bactericidal Assay ( SBA ) , measure effective antibody kill certain bacteria important measure effective new vaccine may . The sample would use laboratory analysis clinical trial vaccine use adult child , sample pre-clinical ( animal ) experiment test new vaccine enter human-stage testing . Most people form protection bacteria already , everyone suitable blood donor laboratory test . We therefore start take small blood sample test one ask blood find suitable work .</brief_summary>
	<brief_title>Complement 2 : Blood Donations Develop Vaccines Against Infectious Diseases</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Complement System Proteins</mesh_term>
	<criteria>Willing able give inform consent participation study Aged 18 70 year In good health determine medical history clinical judgment Investigators Able attend schedule visit comply study procedure If find suitable complement willing approached donation Body weight less 50kgs Have know suspect impairment alteration immune function , result , example : congenital acquire immunodeficiency , receipt immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 12 month longterm systemic corticosteroid therapy , receipt immunoglobulin blood product transfusion within last 3 month Female participant pregnant Any chronic illness could , opinion Investigators , interfere immune function donation large volume blood ( e.g . thrombocytopaenia coagulopathy , malabsorption disorder , chronic anaemia ) An individual delegation log study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Complement</keyword>
	<keyword>Serum Bactericidal Assay</keyword>
</DOC>